JULIE WILLINGHAM: Open Payments
NPI 1568905016 · DEMOREST, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 14 payments from 8 companies in 2025. Trend: 2023 $199 · 2024 $406 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $263 |
| Novo Nordisk Inc | 2 | $51 |
| Lilly USA, LLC | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Eisai Inc. | 1 | $27 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $16 |
Products named: EVENITY, MOUNJARO, XIFAXAN, Ozempic, Leqembi, JOURNAVX, Rybelsus, REXULTI.
Industry payments across GA — which companies pay providers there.
